home / stock / ntra / ntra news


NTRA News and Press, Natera Inc. From 01/22/24

Stock Information

Company Name: Natera Inc.
Stock Symbol: NTRA
Market: NASDAQ
Website: natera.com

Menu

NTRA NTRA Quote NTRA Short NTRA News NTRA Articles NTRA Message Board
Get NTRA Alerts

News, Short Squeeze, Breakout and More Instantly...

NTRA - Top high-quality growth stocks poised to outperform - MS

2024-01-22 11:29:07 ET More on S&P 500 Index: S&P 500 Sets New Record High As Investors Potentially Shift Focus To Q2 2024 Market Rally Met With Outflows S&P 500: The 'Pump' Is Underway - Watch Out For The 'Dump' S&P won't get the helping hand...

NTRA - Invitae offloads reproductive health assets to Natera

2024-01-22 07:51:11 ET More on Natera, Invitae, etc. Stocks To Watch: Energy Market Drama And Financial Earnings Headline Holiday Week Natera: Squeezing The Last Drop From NIPT Growth Engine Invitae Corporation 2023 Q3 - Results - Earnings Call Presentation C...

NTRA - Invitae Completes Sale of Reproductive Health Assets to Natera

Invitae Completes Sale of Reproductive Health Assets to Natera PR Newswire SAN FRANCISCO , Jan. 22, 2024 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced it has completed the sale of certain reproductive health as...

NTRA - Natera Acquires Reproductive Health Assets from Invitae

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing, today announced that it has acquired from Invitae (NYSE: NVTA), a leading medical genetics company, certain assets relating to Invitae’s non-invasive prenatal screening and carrier screening business. Nate...

NTRA - Natera to Present New Data from the CIRCULATE-Japan and BESPOKE CRC Studies at ASCO GI 2024 Supporting Signatera's Clinical Utility in CRC

Oral presentations include updated 24-month DFS analysis from GALAXY and first interim analysis from BESPOKE CRC Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that new data on its personalized and tumor-informed molecular residual disease (MR...

NTRA - Oxford Nanopore: Ultra-Long Reads In A Short-Term Slump

2024-01-17 21:22:40 ET Summary Shares of Oxford Nanopore declined by 33% after slower than expected growth in the second half of 2023. Positive outlook on the company, but profitability not expected until 2026. Challenging market with slow adoption of new technology, but new p...

NTRA - Canaccord says Natera verdict "highlights rock-solid patent portfolio"

2024-01-17 15:51:07 ET More on Natera Natera: Squeezing The Last Drop From NIPT Growth Engine Natera, Inc. (NTRA) Q3 2023 Earnings Call Transcript Natera, Inc. 2023 Q3 - Results - Earnings Call Presentation Piper says RavGen decision largely removes legal ove...

NTRA - Piper says RavGen decision largely removes legal overhang on Natera

2024-01-17 14:27:40 ET More on Natera Natera: Squeezing The Last Drop From NIPT Growth Engine Natera, Inc. (NTRA) Q3 2023 Earnings Call Transcript Natera, Inc. 2023 Q3 - Results - Earnings Call Presentation Natera says jury reached verdict of no willful infri...

NTRA - 4 stocks to watch on Wednesday: Charles Schwab, Impinj and more

2024-01-17 09:23:00 ET U.S. stock index futures on Wednesday were in the red, as some concerns over the trajectory of anticipated interest rate cuts from the previous session continued to weigh on sentiment. Moreover, retail sales data came in hotter-than-expected. Here are some stocks to w...

NTRA - Natera says jury reached verdict of no willful infringement in Ravgen case

2024-01-16 17:30:34 ET More on Natera Natera: Squeezing The Last Drop From NIPT Growth Engine Natera, Inc. (NTRA) Q3 2023 Earnings Call Transcript Natera, Inc. 2023 Q3 - Results - Earnings Call Presentation Natera raises FY23 revenue guidance by $20M to $1.07...

Previous 10 Next 10